295 related articles for article (PubMed ID: 18061175)
1. Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats.
Dresner-Pollak R; Gabet Y; Steimatzky A; Hamdani G; Bab I; Ackerman Z; Weinreb M
Gastroenterology; 2008 Jan; 134(1):259-67. PubMed ID: 18061175
[TBL] [Abstract][Full Text] [Related]
2. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
[TBL] [Abstract][Full Text] [Related]
3. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
Lane NE; Thompson JM; Strewler GJ; Kinney JH
J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
[TBL] [Abstract][Full Text] [Related]
4. Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model.
Lane NE; Kimmel DB; Nilsson MH; Cohen FE; Newton S; Nissenson RA; Strewler GJ
J Bone Miner Res; 1996 May; 11(5):614-25. PubMed ID: 9157776
[TBL] [Abstract][Full Text] [Related]
5. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
[TBL] [Abstract][Full Text] [Related]
7. Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in rats.
Zhang R; Liu ZG; Li C; Hu SJ; Liu L; Wang JP; Mei QB
Bone; 2009 Sep; 45(3):553-9. PubMed ID: 18835589
[TBL] [Abstract][Full Text] [Related]
8. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
Xu D; Yang W; Zhou C; Liu Y; Xu B
Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
[TBL] [Abstract][Full Text] [Related]
9. Anabolic effects of recombinant human parathyroid hormone (1 - 84) and synthetic human parathyroid hormone (1 - 34) on the mandibles of osteopenic ovariectomized rats with maxillary molar extraction.
Kawane T; Takahashi S; Saitoh H; Okamoto H; Kubodera N; Horiuchi N
Horm Metab Res; 2002 Jun; 34(6):293-302. PubMed ID: 12173069
[TBL] [Abstract][Full Text] [Related]
10. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
[TBL] [Abstract][Full Text] [Related]
11. Intermittent administration of human parathyroid Hormone(1-34) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice.
Sakai A; Sakata T; Ikeda S; Uchida S; Okazaki R; Norimura T; Hori M; Nakamura T
J Bone Miner Res; 1999 Oct; 14(10):1691-9. PubMed ID: 10491216
[TBL] [Abstract][Full Text] [Related]
12. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
[TBL] [Abstract][Full Text] [Related]
13. Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice.
Alexander JM; Bab I; Fish S; Müller R; Uchiyama T; Gronowicz G; Nahounou M; Zhao Q; White DW; Chorev M; Gazit D; Rosenblatt M
J Bone Miner Res; 2001 Sep; 16(9):1665-73. PubMed ID: 11547836
[TBL] [Abstract][Full Text] [Related]
14. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone 1-34 enhances titanium implant anchorage in low-density trabecular bone: a correlative micro-computed tomographic and biomechanical analysis.
Gabet Y; Müller R; Levy J; Dimarchi R; Chorev M; Bab I; Kohavi D
Bone; 2006 Aug; 39(2):276-82. PubMed ID: 16617039
[TBL] [Abstract][Full Text] [Related]
17. Human parathyroid hormone (1-34) increases mass and structure of the cortical shell, with resultant increase in lumbar bone strength, in ovariectomized rats.
Arita S; Ikeda S; Sakai A; Okimoto N; Akahoshi S; Nagashima M; Nishida A; Ito M; Nakamura T
J Bone Miner Metab; 2004; 22(6):530-40. PubMed ID: 15490262
[TBL] [Abstract][Full Text] [Related]
18. Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation.
Smith BJ; Lerner MR; Bu SY; Lucas EA; Hanas JS; Lightfoot SA; Postier RG; Bronze MS; Brackett DJ
Bone; 2006 Mar; 38(3):378-86. PubMed ID: 16256450
[TBL] [Abstract][Full Text] [Related]
19. Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway.
Franklin M; Bu SY; Lerner MR; Lancaster EA; Bellmer D; Marlow D; Lightfoot SA; Arjmandi BH; Brackett DJ; Lucas EA; Smith BJ
Bone; 2006 Dec; 39(6):1331-42. PubMed ID: 16890505
[TBL] [Abstract][Full Text] [Related]
20. Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats.
Bonnet N; Laroche N; Vico L; Dolleans E; Benhamou CL; Courteix D
J Pharmacol Exp Ther; 2006 Sep; 318(3):1118-27. PubMed ID: 16740619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
